Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest update is out from Foghorn Therapeutics ( (FHTX) ).
Adam M. Koppel, M.D., Ph.D., has resigned from the board of directors of Foghorn Therapeutics Inc. effective immediately, leaving his roles on the Audit Committee and Nominating and Corporate Governance Committee. His departure was not due to any disagreements with the company’s operations, policies, or practices, and his term was set to expire at the 2025 Annual Meeting.
More about Foghorn Therapeutics
YTD Price Performance: -25.27%
Average Trading Volume: 154,042
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $268M
For an in-depth examination of FHTX stock, go to TipRanks’ Stock Analysis page.
